Why the study?
Pre-test probability models for coronary artery disease are largely derived from male-dominant cohorts and often underestimate risk in women, leaving the incremental predictive value of sex-specific risk factors using explainable AI unexplored.
Does an AI-based pre-test probability model incorporating sex-specific risk factors improve coronary artery disease risk prediction compared to the ESC RF-CL model in patients undergoing coronary CT angiography?
Does an AI-based pre-test probability model incorporating sex-specific risk factors improve coronary artery disease risk prediction compared to the ESC RF-CL model in patients undergoing coronary CT angiography?
Integrating sex-specific risk factors into an explainable AI model markedly enhances pre-test probability estimation and CAD risk prediction in women undergoing coronary CT angiography compared to standard ESC models.
Background Coronary computed tomography angiography (CCTA) has emerged as a powerful non-invasive imaging modality for the evaluation of coronary artery disease (CAD), with a global trend towards a "CT-first" strategy in stable patients with suspected CAD. Pre-test probability (PTP) models stratify risks of CAD for appropriate utilization of CCTA. However, these models are largely derived from male-dominant cohorts and often underestimate CAD risk in women. Purpose This study uses explainable artificial intelligence (AI) for exploration of the incremental predictive power of sex-specific risk (SSR) factors for PTP models. Methods Patients undergoing CCTA for suspected CAD at Cardiology Centers Netherlands were included. The ESC RF-CL model was constructed using raw weights and interaction coefficients. The AI-based SSR-PTP model incorporated classic cardiovascular risk factors and additional SSR factors: thyroid/rheumatic disease, migraines (diagnosed ≤20 years), early menopause (≤40 years), and multiple miscarriages. Missing data (<10%) was imputed via nearest neighbors. A gradient boosting decision tree model (70/30 train-test split, depth 5, learning rate 0.01, 5-fold cross-validation) with isotonic regression calibration was developed. Performance was assessed using discriminatory analysis, bootstrapped 95% confidence intervals (CI), net reclassification index (NRI), and explainable SHAP features. Results Among 4,234 patients (52% women), 69% had CAD and 21% obstructive disease (mean PTP: 0.21 ± 0.09). Additional SSR data was available for 725 patients. The RF-CL model slightly underperformed in women (AUC 0.71 vs 0.74; mean difference (MD): −0.02, 95%CI [−0.06-0.01]; p = 0.23). In the women’s program subset, the AI SSR-PTP model significantly outperformed RF-CL (AUC 0.89 vs 0.68; MD: 0.21, 95%CI 0.12–0.30; p < 0.01), with improved sensitivity (0.78 vs 0.63) and specificity (0.77 vs 0.63). The model was well calibrated (p = 0.74), and reclassification improved (NRI 0.28, 95% CI 0.11–0.45; p = 0.02). SHAP analysis suggested protective associations for thyroid disease and presence of anemia, and increased risk with rheumatic disease or early-life migraines. Conclusion In this large CCTA cohort, integrating SSR factors into an AI-based model markedly enhanced CAD risk prediction and individualized PTP estimation, underscoring the need for sex-sensitive approaches in CAD diagnostics.
No takes yet. Share an insight, caveat, or question.
Hennecken et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: